The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

Piper Sandler analyst Jessica Tassan maintained a Buy rating on UnitedHealth (UNH – Research Report) today and set a price target of $600.00.

Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

According to the Federal Trade Commission, UnitedHealth Group has been charging patients markups on lifesaving drugs. Between ...

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing ...

The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...

UnitedHealth, the biggest insurance company in America, is receiving backlash after an FTC report revealed that it was ...

CVS, Cigna Make Billions Via PBMs On Specialty Drugs "The people of UnitedHealth Group remain focused on making high-quality, affordable health care more available to more people while making the ...